Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)

por Wislez, Marie, Mazieres, Julien, Lavole, Armelle, Zalcman, Gérard, Carre, Olivier, Egenod, Thomas, Caliandro, Raffaele, Dubos-Arvis, Catherine, Jeannin, Gaelle, Molinier, Olivier, Massiani, Marie-Ange, Langlais, Alexandra, Morin, Franck, Le Pimpec Barthes, Francoise, Brouchet, Laurent, Assouad, Jalal, Milleron, Bernard, Damotte, Diane, Antoine, Martine, Westeel, Virginie
Publicado 2022